What men need to know after a major update to prostate cancer guidelines
Middle-aged men should undergo regular screening for prostate cancer, the American Cancer Society said Thursday in a major change to its guidelines.
Nov 13, 2026
0
13
MeSH tree: D12.776.869.250.249
Middle-aged men should undergo regular screening for prostate cancer, the American Cancer Society said Thursday in a major change to its guidelines.
Nov 13, 2026
0
13
In a recent Yale-led clinical trial, a new type of prostate cancer drug showed promising results in reducing tumor activity and pain for patients with metastatic prostate cancer.
Nov 4, 2026
0
411
Prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical therapy is safe and effective for patients with metastatic castration-resistant prostate cancer (mCRPC) in routine clinical practice, consistent with ...
Oct 23, 2026
0
11
A case report led by UCLA Health researchers highlights the importance of a multidisciplinary, evidence-based approach to treating prostate cancer that returns after surgery, particularly when the disease recurs multiple ...
Sep 30, 2026
0
6
Prostate cancer is common. About 200 in every 1,000 Australian men will be told they have prostate cancer by age 85. But the chance of dying from it is much lower: around 18 in 1,000 cases.
Sep 23, 2026
0
5
Three decades after UC San Francisco pioneered "active surveillance" for patients with low-risk prostate cancer, a new study has found that the vast majority of veterans with the diagnosis pursued this option instead of treatment.
Aug 13, 2026
0
11
Researchers with the James P. Allison Institute at The University of Texas MD Anderson Cancer Center have discovered a new gene expression signature within tumors that can help identify patients with metastatic castration-resistant ...
May 21, 2026
0
9
A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than current tests, according to a U.K.-wide study led by UCL researchers. The study, published in Nature ...
May 18, 2026
0
37
Most men with low-grade prostate cancer have an excellent prognosis, with a five-year survival rate of more than 99%. But radical prostatectomy—surgery to remove the prostate—can lead to sexual and physical dysfunction, fatigue, ...
May 11, 2026
0
12
A large analysis of two major clinical trials has found that the spread of prostate cancer can be detected on imaging scans even when biomarkers remain stable in patients treated with androgen receptor inhibitors, according ...
Apr 27, 2026
0
11